INS and inflammatory bowel disease: GLP-1, secreted by ileal L-cells, promotes insulin release, but its action is notably diminished in patients.[45] Changes in the gut environment of patients with IBD, including inflammation, altered secretion of gut hormones, and impaired absorption, collectively influence the effects of incretin.